News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current BXN market cap is 38.89M. The company's latest EPS is AUD -0.0065 and P/E is -3.08.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 2.33M | 2.2M | 2.48M | 5.31M | 9.76M |
| Operating Income | -651k | -255k | -139k | -2M | -13.23M |
| Net Income | -593k | -496k | -237k | -1.94M | -13.33M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 3.34M | 2.68M | 2.92M | 17.69M | 6.7M |
| Total Liabilities | 726k | 745k | 982k | 2.69M | 3.4M |
| Total Equity | 2.61M | 1.93M | 1.94M | 15.01M | 3.3M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 49k | 53k | 435k | -841k | -3.56M |
| Investing | -33k | N/A | -6k | 3.96M | -493k |
| Financing | -52k | -47k | N/A | 947k | 1.21M |
| Market Cap | 38.89M |
| Price to Earnings Ratio | -3.08 |
| Price to Sales Ratio | 4.17 |
| Price to Cash Ratio | 40 |
| Price to Book Ratio | 12.4 |
| Dividend Yield | - |
| Shares Outstanding | 2.05B |
| Average Volume (1 week) | 684.19k |
| Average Volume (1 Month) | 2.6M |
| 52 Week Change | 72.73% |
| 52 Week High | 0.023 |
| 52 Week Low | 0.004 |
| Spread (Intraday) | 0 (5.26%) |
| Company Name | Bioxyne Ltd |
| Address |
suite 506, level 5 sydney, new south wales 2000 |
| Website | https://www.bioxyne.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
